Lv5
1000 积分 2023-06-03 加入
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial
7天前
已完结
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction
13天前
已完结
Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
13天前
已完结
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
13天前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
13天前
已完结
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
17天前
已完结
The Science of Frailty
23天前
已完结
PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous Coronary Intervention in older Patients
26天前
已完结
Optimizing cardiovascular pharmacotherapy in older adults with frailty
2个月前
已完结
Effect of Frailty on In-Hospital Mortality and Complications of PCI
2个月前
已关闭
皖公网安备34019202002308